Transcription: Base J Blocks the Way  by Hazelbaker, Dane Z. & Buratowski, Stephen
Current Biology Vol 22 No 22
R960reported that vertebrate HDAC8 acts
as a cohesin deacetylase and,
remarkably, that mutations in this gene
turn out to be a reason for the human
developmental disorder described as
Cornelia de Lange syndrome. In human
cells treated with an HDAC8 inhibitor,
the cleaved fragments of Scc1 as well
as other cohesin subunits remain
associated with Smc1–Smc3 in G1
phase, whereas such pro-cohesive
complexes are not detected in
untreated cells. Thus, in human cells as
suggested in yeast, the deacetylation
of Smc3 might be required for
disassembly of pro-cohesive cohesin
complex and for recycling refreshed
cohesin for the next cell cycle. Notably,
because both the amino- and
carboxy-terminal Scc1 fragments
remain in the cleaved cohesin
complexes in cells treated with HDAC8
inhibitor [20], the disassembly of the
cohesin complex during anaphase may
occur at both the Smc3–Scc1 and
Smc1–Scc1 interfaces in the cohesin
ring. This is an apparent contradiction
to the yeast study indicating that the
Smc3–Scc1 interface is the sole target
of Wapl and Smc3 deacetylation
(Figure 1). Importantly, in
HDAC8-depleted cells, many cohesin
localization sites exhibit reduced
occupancy, which might lead to the
transcriptional dysregulation observed
in fibroblasts isolated from Cornelia de
Lange syndrome patients [20].
Currently, however, the causal
relationship between the change in
cohesin localization sites and
transcriptional dysregulation is
unknown.
As noted above, it has emerged that
the cohesin protein complex, which
functions in sister chromatid cohesion
and chromosome segregation, also
regulates gene expression. However, it
remains largely unclear how cohesin or
cohesion regulates transcription.
Cohesin dynamics, influenced by
acetylation and Wapl, may modulate
the chromatin topology required for
transcriptional regulation during
interphase. Detailed analysis of the
three-dimensional chromatin
architecture and transcription profile
in Wapl-depleted versus wild-type
cells will advance our understanding of
the link between cohesin and
transcription.
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*E-mail: ywatanab@iam.u-tokyo.ac.jphttp://dx.doi.org/10.1016/j.cub.2012.09.049Transcription: Base J Blocks the WayHow do cells stop transcribing RNA Polymerase II to promote proper gene
expression and prevent transcriptional havoc in the genome? In the case
of Leishmania, a uniquely modified DNA base blocks RNA Polymerase II
and suggests an interesting new model for transcription termination.Dane Z. Hazelbaker
and Stephen Buratowski
Given the pervasive transcription of
eukaryotic genomes [1,2], where RNA
polymerase stops can be just as
important as where it starts. Premature
termination leads to truncated
transcripts and potentially
non-functional gene products.
Conversely, transcription past
a terminator (transcriptional
readthrough) produces defectivereadthrough transcripts and
a trespassing polymerase that can
tamper with downstream genes or
silenced regions. Thus, assuring
efficient termination is vital for
maintaining transcriptional order. To
achieve this, cells generally employ
various termination factors that either
displace or block elongating
polymerase [3,4]. However, a recent
paper from the Myler and Borst labs
suggests that the parasitic
trypanosomatid Leishmania uses
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Figure 1. DNA base J prevents transcriptional readthrough in Leishmania.
High levels of base J (right panel) in DNA termination regions between genes in Leishmania
promote RNA Polymerase II (RNAPII) termination in wild-type (WT) cells. In JBP2 knockout
cells, base J levels in termination regions drop and RNAPII readthrough transcription levels
greatly increase, resulting in the production of longer readthrough transcripts (in red).
Dispatch
R961a novel method to stop RNA
Polymerase II in its tracks. As reported
in Cell, van Luenen et al. [5] find that
a modified thymidine nucleotide, base
J (b-D-glucosyl-hydroxymethyluracil),
localizes at terminator sites throughout
the genomes of two Leishmania
species and is critical for terminating
RNA Polymerase II transcription.
Base J was first discovered in the
trypanosome Trypanosoma brucei
and has since been found in other
kinetoplastids, including Leishmania
[6]. The vast majority of base J
localizes to telomeric repeats, hinting
at a possible role in silencing, yet its
function remained elusive [6,7]. Using
deep-sequencing of base-J-containing
genomic DNA from Leishmania and
chromatin immunoprecipitation of
a base-J-binding protein, van Luenen
et al. find most base J at telomeric
repeats as expected. However, the
rest of base J maps to localized
peaks in between genes: at 3’ ends
of convergent genes and at
promoters of divergent genes. Other
non-telomeric peaks are likely to
mark termination regions between
tandem genes. Deletion of JBP2,
a gene needed for the modification
of thymine to base J, results in loss of
base J across the genome. This effect
is exacerbated when cells are grown in
the presence of the thymidine analogue
bromodeoxyuridine (BrdU). Strikingly,
analysis of RNA transcription in
L. tarentolae cells lacking JBP2 reveals
that readthrough transcription
increases dramatically as base J levels
drop (Figure 1). When JBP2 knockout
cells are exposed to BrdU, base J loss
and readthrough levels are enhanced
and the organisms eventually die
amidst a backdrop of ‘transcriptional
chaos’ [5].
The findings of van Luenen et al. [5]
are surprising, and it is useful to ask
whether they fit into the context of what
is generally known about termination
factors and mechanisms. Many
termination factors directly engage
the transcription elongation complex,
translocating along the nascent
transcript until reaching the
polymerase to trigger termination.
Some of these factors are members
of the ATP-dependent helicase family.
For example, the prokaryotic Rho
protein binds both RNA polymerase
and the nascent transcript, and its
ATP-driven translocation destabilizes
the RNA/DNA hybrid to dissociate
the elongation complex [8]. Similarly,eukaryotic Sen1/Senataxin may act in
a Rho-like fashion to promote RNA
Polymerase II (RNAPII) dissociation
at non-polyadenylated transcripts [9].
By a somewhat different mechanism,
the Rat1/Xrn2 RNA exonuclease
recognizes the new uncapped 5’
end generated by polyadenylation
site cleavage of eukaryotic mRNAs,
and degradation of the remaining
downstream nascent transcript
somehow triggers termination [10,11].
For these ‘chasing’ termination factors,
the relative speeds of the elongating
polymerase and the pursuing factors
influence where termination occurs,
often resulting in 3’ heterogeneity of
transcripts over a ‘termination
window’ [10,12–14].
Polymerase slowing or pausing is
also likely to play a role in termination
[15]. For example, eukaryotic factor
Pcf11 has been proposed to dissociate
RNA polymerase II elongation
complexes by creating a torsional
stress that blocks forward motion [16].
Other termination factors bind specific
DNA sequences to act as roadblocks
to elongation. Yeast Reb1 binds tightly
to specific ribosomal RNA terminator
sequences to block RNA Polymerase I,
thereby allowing time for RNase
III-dependent transcript cleavage
and Rat1/Xrn2-mediated termination
similar to that described above for
RNAPII [17]. Pausing can also occur
in the absence of an exogenous factor,
as certain DNA sequences can slow
elongation or be transcribed to formRNA structures that trigger polymerase
release, as seen for intrinsic
terminators in bacteria [4].
Does base J fit into any of these
known termination mechanisms?
Perhaps the most conspicuous
feature of base J is the bulky glucose
ring (Figure 1). One possibility is that
this large base cannot fit the confines
of the RNAPII active site or properly
orient to achieve base pairing with
incoming nucleotides, effectively
stalling transcribing polymerase. In
this model, base J functions as
a non-protein roadblock. It’s important
to note that Leishmania genes are
expressed as polycistronic transcripts,
which are cleaved into monocistronic
mRNAs that are then polyadenylated
and trans-spliced to 5’ capped leader
sequences [18]. This system, where
cleavage at polyadenylation sites is not
tightly linked to termination, may have
necessitated evolution of a novel or
variant termination mechanism.
Polymerases stalled at base J may
intrinsically undergo release, or sit
until displaced by a chasing
termination factor that is too slow to
catch an elongating RNAPII (Figure 2).
In support of this idea, loss of base J
causes 3’ ends of Leishmania
transcripts to expand from a very
narrow band to a larger spread
reminiscent of the termination window
seen for chasing termination factors
in other organisms. Perusal of the
Leishmania major genome [19] reveals
putative Rat1 and Sen1 homologs,
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Figure 2. Speculative model for RNA Polymerase II termination at base J terminators.
Schematic depiction of a base J roadblock model for RNAPII termination in Leishmania. Tran-
scribing RNAPII (top) encounters high levels of base J in the DNA template strand that stalls
RNAPII by steric occlusion of the active site (middle). This blockage may directly destabilize
and terminate the RNAPII elongation complex or render it susceptible to the action of termi-
nation factors (bottom).
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R962and future experiments can test
whether these are used as termination
factors. Alternatively, base J could
serve as a recruitment signal to localize
termination factors or a mark for
a repressive chromatin structure [5].
Many interesting questions arise
with the discovery of base J’s role
in termination. Perhaps the most
obvious is how base J is targeted to
specific sites in the genome, while
keeping it absent from gene bodies
where it could cause premature
termination. Secondly, how much
base J is needed at a particular locus
to elicit efficient RNAPII termination,
and does it function on template,
non-template, or both strands?
Thirdly, how are base J levels
appropriately maintained in the
genome? After DNA replication,
daughter strands must undergo
rapid modification to maintain base J
levels and termination, implying either
an efficient de novo targeting system
or some type of epigenetic inheritance.Finally, in most eukaryotes,
polymerase stalling at modified
bases (such as those with bulky
adducts induced by chemical
damage) elicits transcription-coupled
repair to induce their removal [20].
This might imply these DNA repair
pathways are not active in Leishmania
or that base-J-stalled RNAPII
somehow avoids triggering these
repair machineries.
All in all, the intriguing results in van
Luenen et al. [5] suggest it is only the
beginning of our understanding of base
J’s role in transcription’s end.
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